HealthStream (HSTM)
(Delayed Data from NSDQ)
$26.05 USD
+0.40 (1.56%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $26.01 -0.04 (-0.15%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HSTM 26.05 +0.40(1.56%)
Will HSTM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HSTM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HSTM
HealthStream (HSTM) Surpasses Q2 Earnings Estimates
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
HSTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?
Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot?
Here's Why HealthStream (HSTM) is Poised for a Turnaround After Losing -13.2% in 4 Weeks
Other News for HSTM
HealthStream Inc (HSTM) Q2 2025: Everything You Need To Know Ahead Of Earnings
HSTM Projected to Achieve Net Income Growth by 2025
HealthStream (HSTM) Reports Record Q2 Revenue, Exceeds Expectations
HealthStream GAAP EPS of $0.18 beats by $0.02, revenue of $74.4M in-line
HealthStream Inc Q2 2025 Earnings: EPS of $0.18 Beats Estimate, Revenue Hits $74.4 Million